FDA approves AstraZeneca's asthma injection

05:40 EST 15 Nov 2017 | pharmaphorum

The FDA has approved AstraZeneca’s asthma injection, benralizumab, offering a more patient-friendly eight-week dosing regimen that could give an edge over rivals from GlaxoSmithKline and Teva. Branded as Fasenra, benralizumab is part of a new wa...

Original Article: FDA approves AstraZeneca's asthma injection


More From BioPortfolio on "FDA approves AstraZeneca's asthma injection"

Quick Search


Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...